Johnson & Johnson (NYSE:JNJ): Current price $74.08
The European Commission has sent antitrust objections to Novartis (NYSE:NVS) and Johnson & Johnson in regards to a pay-for-delay arrangement that might have deterred sales of generic versions of pain killer fentanyl in the Netherlands. The Commission charged that the Dutch divisions of both firms made a so-called co-promotion agreement in July 2005 to avert competing against each other, which results deprived Dutch fentanyl customers access to a less expensive pain killer for 17 months.
Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.